Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

AbbVie Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis reveals significant fluctuations in the relationship between Return on Assets (ROA), Financial Leverage, and Return on Equity (ROE) over the observed period. Initially, ROE demonstrates a strong performance, subsequently experiencing considerable volatility and a marked increase towards the end of the period.

Return on Assets (ROA)
ROA exhibits a generally decreasing trend throughout the period. Starting at 8.71% in March 2022, it peaks at 9.49% in September 2022 before declining to 3.15% by December 2025. This suggests a diminishing ability to generate profit from its asset base. The most substantial declines occur between September 2023 and December 2024.
Financial Leverage
Financial Leverage shows a substantial upward trend, particularly pronounced in the later quarters. Beginning at 8.80 in March 2022, it steadily increases, with a significant jump to 18.59 in March 2024. The most dramatic increase is observed between March 2024 and December 2024, reaching 40.65, and then a further increase to 95.89 in March 2025. This indicates an increasing reliance on debt financing. The lack of values for September 2025 and December 2025 suggests a potential reporting change or data unavailability.
Return on Equity (ROE)
ROE initially mirrors the positive trend of ROA and Financial Leverage, peaking at 86.24% in June 2022. However, it then experiences a decline, reaching a low of 46.94% in December 2022. Subsequently, ROE begins to rise again, accelerating sharply in line with the increasing Financial Leverage, culminating in an exceptionally high value of 295.42% in March 2025. This suggests that the increases in ROE are largely driven by the increasing use of financial leverage, rather than improvements in asset efficiency. The substantial increase in ROE, coupled with the dramatic rise in Financial Leverage, warrants further investigation into the sustainability of this performance and the associated financial risks.

The observed pattern indicates a shift in the company’s financial strategy towards greater reliance on debt. While this has resulted in higher ROE figures in recent periods, the escalating Financial Leverage also introduces increased financial risk. The declining ROA suggests that the company is becoming less efficient in utilizing its assets to generate profit, making the increased leverage a more critical factor in driving ROE.


Three-Component Disaggregation of ROE

AbbVie Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of the presented financial metrics reveals significant fluctuations in the components of Return on Equity (ROE) over the observed period. Net Profit Margin, Asset Turnover, and Financial Leverage all exhibit distinct trends that contribute to the overall changes in ROE.

Net Profit Margin
The Net Profit Margin demonstrated initial stability between March 2022 and June 2022, holding at approximately 22%. A peak was reached in September 2022 at 23.19%, followed by a decline to 20.39% by the end of 2022. A substantial decrease occurred in the first half of 2023, falling to a low of 13.37% in March 2023 before a partial recovery to 15.50% in June 2023. Further declines were observed throughout 2023 and into 2024, reaching a low of 7.59% in December 2024. A slight increase to 6.91% is noted in December 2025, but remains significantly lower than earlier periods.
Asset Turnover
Asset Turnover remained relatively stable between March 2022 and June 2023, fluctuating between 0.40 and 0.42. A slight decrease to 0.37 was observed in March 2024, followed by a recovery to 0.42 in December 2024. The metric continued to increase through the observed period, reaching 0.46 in December 2025.
Financial Leverage
Financial Leverage exhibited an increasing trend throughout most of the period. Starting at 8.80 in March 2022, it rose to a peak of 13.00 in December 2023. A dramatic increase occurred in March 2024, reaching 18.59, and continued to climb sharply, peaking at 40.65 in December 2024. While the most recent values are unavailable, the substantial increase in leverage is a key observation.
Return on Equity (ROE)
ROE initially demonstrated strong performance, peaking at 86.24% in June 2022. A decline was observed through 2022, reaching 68.60% in December 2022, largely mirroring the decrease in Net Profit Margin. ROE recovered somewhat in the first half of 2023, but then experienced significant volatility. The most dramatic increase in ROE occurred in December 2024, reaching 128.66%, and further increasing to 295.42% in March 2025. This substantial increase in ROE is primarily driven by the significant increase in Financial Leverage, despite the declining Net Profit Margin.

The interplay between these three components has resulted in a complex ROE trajectory. While the Net Profit Margin has generally decreased, the increasing Financial Leverage has exerted a dominant influence on ROE, particularly in the latter part of the observed period. The Asset Turnover has remained relatively stable, contributing less to the overall fluctuations in ROE. The substantial increase in leverage warrants further investigation to assess its sustainability and potential risks.


Two-Component Disaggregation of ROA

AbbVie Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of the presented financial metrics reveals a notable shift in profitability and efficiency over the observed period. Return on Assets (ROA) experienced a decline from a high of 9.49% in September 2022 to a low of 1.78% in September 2025, before a partial recovery to 3.15% in December 2025. This fluctuation in ROA can be attributed to concurrent movements in Net Profit Margin and Asset Turnover.

Net Profit Margin
The Net Profit Margin demonstrated initial stability around 22% in the first half of 2022, peaking at 23.19% in September 2022. A consistent downward trend followed, reaching a low of 4.00% in September 2025. A modest increase to 6.91% was observed in December 2025. This suggests increasing cost pressures or decreasing pricing power over time.
Asset Turnover
Asset Turnover remained relatively stable between 0.40 and 0.42 from March 2022 through December 2022. A gradual decline commenced in 2023, reaching 0.37 in March 2024. The ratio then exhibited a recovery, increasing to 0.46 by December 2025. This indicates a changing efficiency in utilizing assets to generate sales, with a period of decreased efficiency followed by improvement.

The decline in ROA from 2022 to 2025 largely correlates with the decreasing Net Profit Margin, particularly pronounced in the latter half of the period. While Asset Turnover initially remained stable, its subsequent decline contributed to the overall reduction in ROA. The partial recovery in Asset Turnover during the final quarter suggests potential improvements in operational efficiency, though this was not sufficient to fully offset the impact of the lower profit margin. The interplay between these two components highlights a shift in the drivers of profitability, with margin compression becoming a more significant factor in determining overall returns.

ROA Decomposition
Initially, ROA was sustained by a combination of healthy margins and consistent asset utilization. However, as the Net Profit Margin decreased, the company became more reliant on Asset Turnover to maintain ROA. The eventual decline in both components resulted in a substantial decrease in overall profitability as measured by ROA. The recent uptick in Asset Turnover offers a potential avenue for future ROA improvement, contingent upon stabilizing or improving the Net Profit Margin.

The observed trends suggest a need for further investigation into the factors driving the decline in Net Profit Margin, such as changes in cost structure, competitive pressures, or product mix. Monitoring the sustainability of the Asset Turnover improvement will also be crucial in assessing the company’s ability to restore profitability.